Pharmaceutical Industry Reports Disruptive Behavior Disorder (DBD) Medication, | Page 2

REPORT DESCRIPTION
Disruptive Behavior Disorder (DBD) Medication Market – Overview
Disruptive behavior disorder comprises a group of disorders including oppositional defiant disorder,
conduct disorder, and intermittent explosive disorder. It usually affects young people below 18 years of
age. Children/teenagers suffering from this disorder are unable to regulate her/his emotions and behaviors,
act defiant, and are in conflict with other peers in surrounding thereby facing low quality of life at home,
school, or both. Various causes of DBD include child abuse or neglect, a traumatic life experience, such as
sexual abuse or violence, and a family history of DBDs. DBDs can be treated with variety of option,
initiated with psychological therapy. Under psychological therapy, counselling and guidance is provided
either to parent or child alone, or family together, to improve response to incidence of DBDs. Medication
treatment is preferred either in combination with psychological treatment or started when psychological
therapy proves to be insufficient.
Major factors responsible for growth of the disruptive behavior disorder medication market are rising
burden of the disruptive behavior disorders worldwide, increasing awareness amongst parent about this
disorder, and improvement of psychotic and medication treatment.
© Coherent market Insights. All Rights Reserved